Workflow
Global Macro Investing
icon
Search documents
Novo: Back From The Dead
Seeking Alpha· 2026-01-21 14:15
James Foord is an economist by trade and has been analyzing global markets for the past decade. He leads the investing group The Pragmatic Investor where the focus is on building robust and truly diversified portfolios that will continually preserve and increase wealth. The Pragmatic Investor covers global macro, international equities, commodities, tech and cryptocurrencies and is designed to guide investors of all levels in their journey. Features include a The Pragmatic Investor Portfolio, weekly market ...
Ray Dalio Reflects on 2025
As a global macro investor, I look at the biggest forces, you know, uh markets, um economies, uh politics, geopolitics, and I bet on them, right. And so, uh 2025 was a very interesting year and I see it very different from most how most people see it. In other words, most people think that the biggest story was uh AI and tech and tech stocks and that was the best investment.Wrong. Okay. It was not.uh the biggest investment was gold and the depreciation of the value of fiat money as we know it. Most people t ...
This Investor Beat the Market for 3 Decades Without a Single Losing Year. 3 Stocks He’s Buying Now.
Yahoo Finance· 2025-11-24 17:38
Investment Insights - Stanley Druckenmiller, a highly successful investor, is investing in Natera (NASDAQ:NTRA), Insmed (NASDAQ:INSM), and Teva Pharmaceutical (NYSE:TEVA) [1] - Druckenmiller has a long history of high returns in global macro investing, producing average annual returns of around 30% with no losing years at Duquesne Capital Management from 1981 to 2010 [5][8] Natera (NTRA) - Natera is a genetic testing company specializing in cell-free DNA (cfDNA) for diagnostic tests, including non-invasive prenatal tests [6] - NTRA stock has increased over 500% since its low in October 2023, with revenue rising 34.66% year-over-year in Q3 2025, beating analyst estimates by 13.9% [7] - Management has raised full-year revenue guidance to between $2.18 billion and $2.26 billion, following a previous increase in Q2 2025 [7] Insmed (INSM) - Insmed's stock price surged from below $26 in May 2024 to nearly $200, with revenue growing 52% year-over-year in Q3 2025 [8]
Things are Changing, Let me Explain
World Order & Economic Cycles - The speaker emphasizes the importance of understanding the changing world order and its underlying mechanics [2] - The speaker highlights the cyclical nature of monetary, domestic political, and global world orders, noting their eventual breakdown [2] - The speaker suggests that understanding these cycles is crucial, especially now, given the brink of major changes [2] Author's Intent & Background - The speaker, a 75-year-old global macro investor with 50 years of experience, aims to share accumulated knowledge [1] - The speaker has authored a book and created a video, both titled "Changing World Order," to explain current events [2] - The speaker's upcoming book, releasing on June 3rd, focuses on how countries go broke [2] Communication Strategy - The speaker intends to communicate through various means, including videos and written communications, to stay connected [2]